The global antibiotic drugs market was valued at USD 43.6 billion in 2022 and is expected to reach USD 64.9 billion by 2033. The sales of antibiotic drugs are set to gain traction over the forecast years with a CAGR of around 3.7%.
| Attributes | Key Statistics |
|---|---|
| Market Value (2022) | USD 43.6 billion |
| Market Value (2023) | USD 45.0 billion |
| Market Value (2033) | USD 64.9 billion |
| Estimated Growth (2023 to 2033) | 3.7 % CAGR |
| Share of Top 5 Countries | 66.2% |
Emergence of Infectious Diseases
Expansion in Product Portfolio
The antibiotic drugs market exhibited a CAGR of 2.9% between 2017 and 2022. In 2022, the global market for anti-infective medicines accounted for around USD 76.7 billion, of which antibiotics have a share of USD 43.6 billion.
| Attributes | Key Statistics |
|---|---|
| Market Value (2021) | USD 42.3 billion |
| Estimated Growth (2017 to 2022) | 2.90 % CAGR |
The rising antibiotic treatment for bacterial infections to prevent them from spreading has spurred the global demand for antibiotics. In India, the percentage of single antibiotics consumption is around 4.1 billion, according to the National Library of Medicine. The WHO report on antibiotic usage surveillance, published in 2018, examined data from 65 countries. As determined by daily dosages per 1,000 inhabitants with a rate of 64.4, Mongolia had the most prominent consumption. At 4.4, Burundi received the lowest score. The most popular antibiotics consumed were amoxicillin and amoxicillin/clavulanic acid.
New entity development is more time- and money-consuming; it can take a substantial financial burden and several years to complete. Therefore, it is anticipated that the market for antibiotics can be hampered by the high cost of medication research and the rigorous regulatory approval process.
Adverse effects might result from inadequate knowledge of antibiotic administration and the indiscriminate use of antibiotics for minor infections. As a result, it is anticipated that the growing demand for antibiotics will be hampered by the increased side effects brought on by the emergence of resistance and other adverse side effects. For instance, taking a quinolone antibiotic and a systemic corticosteroid may cause tendon injury.
Antibiotic-resistant microorganisms have emerged due to improper antibiotic use and misuse. Antibiotics' potential danger goes beyond the development of antimicrobial resistance, and excessive use of them is linked to adverse consequences on patients, which are particularly obvious in critically ill patients in intensive care units.
Antibiotics are frequently administered to treat illnesses or symptoms that don't react to them or are likely to go away on their own. Additionally, inappropriate or inadequate antibiotics are administered for some bacterial illnesses. Therefore, these factors contribute to the restraint of the growth of the antibiotic drugs market.
| Top Countries | CAGR |
|---|---|
| United States | 12.1% |
| China | 8.2% |
| India | 6.1% |
| United Kingdom | 4.3% |
| Germany | 3.1% |
The United States is dominating the antibiotic drugs market with a share of 12.1%. The market was valued at USD 5.1 billion in 2022.
The American healthcare system is renowned for its high costs and sophisticated infrastructure. The United States government and regulatory authorities are implementing a variety of cost-effective healthcare schemes to curb catheter-associated UTIs and other infectious diseases. Furthermore, there is a growing need for antibiotics as a result of the increased occurrence of ventilator-associated infections.
According to the Centers for Disease Control and Prevention (CDC), more than 2.8 billion antimicrobial-resistant illnesses occur in the United States each year, resulting in more than 35,000 deaths. The United States government is undertaking several preventative and infection control strategies to reduce the number of illnesses and fatalities caused by antibiotic-resistant bacteria. The United States market for antibiotics is now experiencing significant growth opportunities.
China is an emerging antibiotic drug market with a market share of 8.2%, with a valuation of USD 3.4 billion in 2022.
The pharmaceutical market in China is the second-leading in the world and is further expanding rapidly. China's OTC pharmaceutical business is still enticing, with a sizable market share. According to OEC (Observatory of Economic Complexity), China was the world's top supplier of antibiotics in 2020, with shipments amounting to USD 3.98 billion.
The healthcare industry in China has expanded significantly, allowing it to transition from a base for the production of pharmaceuticals to a vital research and development center. As a result, China has strengthened its position as a strategic player in the global pharmaceutical industry, acting as a foundation for increasing research and development while also functioning as a consumer nation. With all these factors combined, the market of antibiotic drugs in China is one of the emerging and lucrative markets.
India is an emerging market and accounted for a market share of more than 6.1% in 2022.
In recent years, small and leading biopharmaceutical businesses in India have relied on the contract research organization (CRO) industry to supply research services to their R&D operations. However, as the majority of medicines in the pipeline are predicted to reach the end stage and be commercialized by the end of the decade, it is anticipated that the need for antibiotics will rise.
Due to the existence of multiple government-funded medical and pharmaceutical institutions with state-of-the-art equipment, clinical trials and research are now a significant industry in India. For multi-centered clinical studies, these facilities are appropriate. These factors are making India one of the new emerging antibiotic drug markets.
Penicillin-based products dominate the market for antibiotics worldwide. The penicillin antibiotics segment is anticipated to rule the worldwide antibiotics market throughout the forecast period.
| Top Product Type | Penicillins |
|---|---|
| CAGR | 3.6% |
The acceptance of penicillin as a first-line antibiotic therapy and the rising demand for antibiotics to treat various bacterial infections are expected to increase the need for penicillin globally.
People typically contract an infection by contacting infected individuals, eating or drinking contaminated food or water (sometimes called food poisoning), or handling contaminated objects like cutlery, taps, toys, etc.
| Top Indication | Gastrointestinal Infections |
|---|---|
| CAGR | 3.5% |
This results in an increased prevalence of gastrointestinal infection or gastroenteritis. Hence, it had a market share of 26.0% in 2022.
The parenteral route of drug administration occupied 68.6% of global market share in 2022. Intravenous (IV), intramuscular (IM), and subcutaneous parenteral methods are the most significant and often utilized parenteral routes (SC).
| Top Route of Administration | Parenteral |
|---|---|
| CAGR | 3.5% |
For medications with limited GIT absorption and medicines like insulin that are unstable in the GIT, the parenteral route of drug administration is the preferred method.
To expand their product offerings and boost the competitiveness of their companies, the key market participants focus on introducing several effective medications and winning regulatory body clearance. Additionally, businesses are increasingly focusing on expanding their business globally by setting up new labs and facilities to enhance their market presence.
Recent Development
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, South Africa, North Africa, and GCC Countries. |
| Key Segments Covered | Drug Class, Indication, Route of Administration, Distribution Channel, and Region |
| Key Companies Profiled | Abbott Laboratories; AbbVie; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Merck & Co. Inc.; Mylan N.V.; Novartis International AG (Sandoz); Sanofi; Teva Pharmaceutical Industries Ltd.; Melinta Therapeutics; Pfizer Inc; Basilea Pharmaceutica Ltd.; Tetraphase Pharmaceuticals; Paratek Pharmaceuticals, Inc.; Nabriva Therapeutics plc; Spero Therapeutics |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Table 01: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 02: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 03: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 04: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 05: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 08: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 09: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 10: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 13: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 14: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 15: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 17: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 18: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 19: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 20: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 21: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 22: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 23: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 24: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 25: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 26: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 27: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 28: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 29: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 30: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 31: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 32: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 33: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 34: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 35: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Table 36: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 37: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product
Table 38: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication
Table 39: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration
Table 40: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 02: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2033
Figure 04: Global Market Value Share (%) Analysis 2023 and 2033, by Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
Figure 06: Global Market Attractiveness Analysis 2023 to 2033, by Product
Figure 07: Global Market Value Share (%) Analysis 2023 and 2033, by Indication
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Indication
Figure 09: Global Market Attractiveness Analysis 2023 to 2033, by Indication
Figure 10: Global Market Value Share (%) Analysis 2023 and 2033, by Route of Administration
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Route of Administration
Figure 12: Global Market Attractiveness Analysis 2023 to 2033, by Route of Administration
Figure 13: Global Market Value Share (%) Analysis 2023 and 2033, by Distribution Channel
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
Figure 15: Global Market Attractiveness Analysis 2023 to 2033, by Distribution Channel
Figure 16: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 17: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 18: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 19: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 20: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 21: North America Market Value Share, by Product (2023 E)
Figure 22: North America Market Value Share, by Indication (2023 E)
Figure 23: North America Market Value Share, by Route of Administration (2023 E)
Figure 24: North America Market Value Share, by Distribution Channel (2023 E)
Figure 25: North America Market Value Share, by Country (2023 E)
Figure 26: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 27: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 28: North America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 30: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 31: USA Market Value Proportion Analysis, 2022
Figure 32: Global Vs. USA Growth Comparison
Figure 33: USA Market Share Analysis (%) by Product, 2022 to 2033
Figure 34: USA Market Share Analysis (%) by Indication, 2022 to 2033
Figure 35: USA Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 36: USA Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 37: Canada Market Value Proportion Analysis, 2022
Figure 38: Global Vs. Canada. Growth Comparison
Figure 39: Canada Market Share Analysis (%) by Product, 2022 to 2033
Figure 40: Canada Market Share Analysis (%) by Indication, 2022 to 2033
Figure 41: Canada Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 42: Canada Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 43: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 44: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 45: Latin America Market Value Share, by Product (2023 E)
Figure 46: Latin America Market Value Share, by Indication (2023 E)
Figure 47: Latin America Market Value Share, by Route of Administration (2023 E)
Figure 48: Latin America Market Value Share, by Distribution Channel (2023 E)
Figure 49: Latin America Market Value Share, by Country (2023 E)
Figure 50: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 51: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 52: Latin America Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 53: Latin America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 54: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 55: Mexico Market Value Proportion Analysis, 2022
Figure 56: Global Vs Mexico Growth Comparison
Figure 57: Mexico Market Share Analysis (%) by Product, 2022 to 2033
Figure 58: Mexico Market Share Analysis (%) by Indication, 2022 to 2033
Figure 59: Mexico Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 60: Mexico Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 61: Brazil Market Value Proportion Analysis, 2022
Figure 62: Global Vs. Brazil. Growth Comparison
Figure 63: Brazil Market Share Analysis (%) by Product, 2022 to 2033
Figure 64: Brazil Market Share Analysis (%) by Indication, 2022 to 2033
Figure 65: Brazil Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 66: Brazil Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 67: Argentina Market Value Proportion Analysis, 2022
Figure 68: Global Vs Argentina Growth Comparison
Figure 69: Argentina Market Share Analysis (%) by Product, 2022 to 2033
Figure 70: Argentina Market Share Analysis (%) by Indication, 2022 to 2033
Figure 71: Argentina Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 72: Argentina Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 73: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 74: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 75: Europe Market Value Share, by Product (2023 E)
Figure 76: Europe Market Value Share, by Indication (2023 E)
Figure 77: Europe Market Value Share, by Route of Administration (2023 E)
Figure 78: Europe Market Value Share, by Distribution Channel (2023 E)
Figure 79: Europe Market Value Share, by Country (2023 E)
Figure 80: Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 81: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 82: Europe Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 83: Europe Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 84: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 85: UK Market Value Proportion Analysis, 2022
Figure 86: Global Vs. UK Growth Comparison
Figure 87: UK Market Share Analysis (%) by Product, 2022 to 2033
Figure 88: UK Market Share Analysis (%) by Indication, 2022 to 2033
Figure 89: UK Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 90: UK Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 91: Germany Market Value Proportion Analysis, 2022
Figure 92: Global Vs. Germany Growth Comparison
Figure 93: Germany Market Share Analysis (%) by Product, 2022 to 2033
Figure 94: Germany Market Share Analysis (%) by Indication, 2022 to 2033
Figure 95: Germany Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 96: Germany Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 97: Italy Market Value Proportion Analysis, 2022
Figure 98: Global Vs. Italy Growth Comparison
Figure 99: Italy Market Share Analysis (%) by Product, 2022 to 2033
Figure 100: Italy Market Share Analysis (%) by Indication, 2022 to 2033
Figure 101: Italy Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 102: Italy Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 103: France Market Value Proportion Analysis, 2022
Figure 104: Global Vs France Growth Comparison
Figure 105: France Market Share Analysis (%) by Product, 2022 to 2033
Figure 106: France Market Share Analysis (%) by Indication, 2022 to 2033
Figure 107: France Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 108: France Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 109: Spain Market Value Proportion Analysis, 2022
Figure 110: Global Vs Spain Growth Comparison
Figure 111: Spain Market Share Analysis (%) by Product, 2022 to 2033
Figure 112: Spain Market Share Analysis (%) by Indication, 2022 to 2033
Figure 113: Spain Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 114: Spain Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 115: Russia Market Value Proportion Analysis, 2022
Figure 116: Global Vs Russia Growth Comparison
Figure 117: Russia Market Share Analysis (%) by Product, 2022 to 2033
Figure 118: Russia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 119: Russia Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 120: Russia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 121: BENELUX Market Value Proportion Analysis, 2022
Figure 122: Global Vs BENELUX Growth Comparison
Figure 123: BENELUX Market Share Analysis (%) by Product, 2022 to 2033
Figure 124: BENELUX Market Share Analysis (%) by Indication, 2022 to 2033
Figure 125: BENELUX Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 126: BENELUX Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 127: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 128: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 129: East Asia Market Value Share, by Product (2023 E)
Figure 130: East Asia Market Value Share, by Indication (2023 E)
Figure 131: East Asia Market Value Share, by Route of Administration (2023 E)
Figure 132: East Asia Market Value Share, by Distribution Channel (2023 E)
Figure 133: East Asia Market Value Share, by Country (2023 E)
Figure 134: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 135: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 136: East Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 137: East Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 138: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 139: China Market Value Proportion Analysis, 2022
Figure 140: Global Vs. China Growth Comparison
Figure 141: China Market Share Analysis (%) by Product, 2022 to 2033
Figure 142: China Market Share Analysis (%) by Indication, 2022 to 2033
Figure 143: China Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 144: China Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 145: Japan Market Value Proportion Analysis, 2022
Figure 146: Global Vs. Japan Growth Comparison
Figure 147: Japan Market Share Analysis (%) by Product, 2022 to 2033
Figure 148: Japan Market Share Analysis (%) by Indication, 2022 to 2033
Figure 149: Japan Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 150: Japan Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 151: South Korea Market Value Proportion Analysis, 2022
Figure 152: Global Vs South Korea Growth Comparison
Figure 153: South Korea Market Share Analysis (%) by Product, 2022 to 2033
Figure 154: South Korea Market Share Analysis (%) by Indication, 2022 to 2033
Figure 155: South Korea Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 156: South Korea Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 157: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 158: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 159: South Asia Market Value Share, by Product (2023 E)
Figure 160: South Asia Market Value Share, by Indication (2023 E)
Figure 161: South Asia Market Value Share, by Route of Administration (2023 E)
Figure 162: South Asia Market Value Share, by Distribution Channel (2023 E)
Figure 163: South Asia Market Value Share, by Country (2023 E)
Figure 164: South Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 165: South Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 166: South Asia Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 167: South Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 168: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 169: India Market Value Proportion Analysis, 2022
Figure 170: Global Vs. India Growth Comparison
Figure 171: India Market Share Analysis (%) by Product, 2022 to 2033
Figure 172: India Market Share Analysis (%) by Indication, 2022 to 2033
Figure 173: India Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 174: India Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 175: Indonesia Market Value Proportion Analysis, 2022
Figure 176: Global Vs. Indonesia Growth Comparison
Figure 177: Indonesia Market Share Analysis (%) by Product, 2022 to 2033
Figure 178: Indonesia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 179: Indonesia Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 180: Indonesia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 181: Malaysia Market Value Proportion Analysis, 2022
Figure 182: Global Vs. Malaysia Growth Comparison
Figure 183: Malaysia Market Share Analysis (%) by Product, 2022 to 2033
Figure 184: Malaysia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 185: Malaysia Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 186: Malaysia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 187: Thailand Market Value Proportion Analysis, 2022
Figure 188: Global Vs. Thailand Growth Comparison
Figure 189: Thailand Market Share Analysis (%) by Product, 2022 to 2033
Figure 190: Thailand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 191: Thailand Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 192: Thailand Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 193: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 194: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 195: Oceania Market Value Share, by Product (2023 E)
Figure 196: Oceania Market Value Share, by Indication (2023 E)
Figure 197: Oceania Market Value Share, by Route of Administration (2023 E)
Figure 198: Oceania Market Value Share, by Distribution Channel (2023 E)
Figure 199: Oceania Market Value Share, by Country (2023 E)
Figure 200: Oceania Market Attractiveness Analysis by Product, 2023 to 2033
Figure 201: Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 202: Oceania Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 203: Oceania Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 204: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 205: Australia Market Value Proportion Analysis, 2022
Figure 206: Global Vs. Australia Growth Comparison
Figure 207: Australia Market Share Analysis (%) by Product, 2022 to 2033
Figure 208: Australia Market Share Analysis (%) by Indication, 2022 to 2033
Figure 209: Australia Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 210: Australia Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 211: New Zealand Market Value Proportion Analysis, 2022
Figure 212: Global Vs New Zealand Growth Comparison
Figure 213: New Zealand Market Share Analysis (%) by Product, 2022 to 2033
Figure 214: New Zealand Market Share Analysis (%) by Indication, 2022 to 2033
Figure 215: New Zealand Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 216: New Zealand Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 217: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 218: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 219: Middle East & Africa Market Value Share, by Product (2023 E)
Figure 220: Middle East & Africa Market Value Share, by Indication (2023 E)
Figure 221: Middle East & Africa Market Value Share, by Route of Administration (2023 E)
Figure 222: Middle East & Africa Market Value Share, by Distribution Channel (2023 E)
Figure 223: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 224: Middle East & Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 225: Middle East & Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 226: Middle East & Africa Market Attractiveness Analysis by Route of Administration, 2023 to 2033
Figure 227: Middle East & Africa Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 228: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 229: GCC Countries Market Value Proportion Analysis, 2022
Figure 230: Global Vs GCC Countries Growth Comparison
Figure 231: GCC Countries Market Share Analysis (%) by Product, 2022 to 2033
Figure 232: GCC Countries Market Share Analysis (%) by Indication, 2022 to 2033
Figure 233: GCC Countries Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 234: GCC Countries Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 235: Türkiye Market Value Proportion Analysis, 2022
Figure 236: Global Vs. Türkiye Growth Comparison
Figure 237: Türkiye Market Share Analysis (%) by Product, 2022 to 2033
Figure 238: Türkiye Market Share Analysis (%) by Indication, 2022 to 2033
Figure 239: Türkiye Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 240: Türkiye Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 241: South Africa Market Value Proportion Analysis, 2022
Figure 242: Global Vs. South Africa Growth Comparison
Figure 243: South Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 244: South Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 245: South Africa Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 246: South Africa Market Share Analysis (%) by Distribution Channel, 2022 to 2033
Figure 247: North Africa Market Value Proportion Analysis, 2022
Figure 248: Global Vs North Africa Growth Comparison
Figure 249: North Africa Market Share Analysis (%) by Product, 2022 to 2033
Figure 250: North Africa Market Share Analysis (%) by Indication, 2022 to 2033
Figure 251: North Africa Market Share Analysis (%) by Route of Administration, 2022 to 2033
Figure 252: North Africa Market Share Analysis (%) by Distribution Channel, 2022 to 2033
The global market is likely to be worth USD 45 billion in 2023.
The market is expected to reach USD 64.9 billion by 2033.
North America holds 23.9% of the global market in 2022, with the United States being the leading contributor.
China's market is offering lucrative growth, with a market share of 8.2% in 2022.
The United States, China, India, the United Kingdom, and Germany are the top 5 countries.
From 2017 to 2022, the market for antibiotic drugs expanded at the rate of 2.9%.
Pfizer, Sanofi SA, AbbVie Inc. (Allergan plc), Teva Pharmaceuticals, GlaxoSmithKline plc, Novartis AG, Abbott Laboratories, etc.
Explore Similar Insights
Antibiotic Drug Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
